| Good residual function group (n = 179) | Poor residual function group (n = 112) | P value |
---|---|---|---|
Age | 47.0 [38.0;54.5] | 47.0 [38.5;55.0] | .84 |
Gender (male/female) | 111 (62.0%) / 68 (38.0%) | 79 (70.5%) / 33 (29.5%) | .18 |
Height (cm) | 164.0 [158.0;171.0] | 167.5 [160.0;172.0] | .03 |
Weight (kg) | 60.5 ± 9.7 | 65.2 ± 12.2 | .00 |
BMI | 22.3 ± 3.0 | 23.4 ± 3.4 | .00 |
Pre-transplant dialysis duration (month) | 36.0 [5.0;72.0] | 48.0 [12.0;72.0] | .12 |
Pre-transplant dialysis type | Â | Â | .53 |
 HD | 108 (60.3%) | 66 (58.9%) |  |
 PD | 44 (24.6%) | 33 (29.5%) |  |
 HD + PD | 10 (5.6%) | 7 (6.2%) |  |
 None | 17 (9.5%) | 6 (5.4%) |  |
Pre-operative eGFR (ml/min/1.73m2) | 5.5 [4.3; 7.6] | 5.3 [4.0; 7.0] | .15 |
KT history | Â | Â | .59 |
 1st | 167 (93.3%) | 107 (95.5%) |  |
 2nd | 12 (6.7%) | 5 (4.5%) |  |
ABO incompatibility | Â | Â | .43 |
 Matched | 170 (95.0%) | 103 (92.0%) |  |
 Un-matched | 9 (5.0%) | 9 (8.0%) |  |
Donated Kidney | Â | Â | .31 |
 Living | 84 (46.9%) | 45 (40.2%) |  |
 Deceased | 95 (53.1%) | 67 (59.8%) |  |
HBV positive | 15 (8.4%) | 13 (11.6%) | .48 |
HCV positive | 3 (1.7%) | 2 (1.8%) | 1.00 |
Nephropathy positive | 10 (5.6%) | 9 (8%) | .56 |
HTN positive | 155 (86.6%) | 103 (92.0%) | .22 |
DM positive | 44 (24.6%) | 30 (26.8%) | .77 |